Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

TRIUMPH I: Double Blind Placebo Controlled Clinical Investigation Into the Efficacy and Tolerability of Inhaled Treprostinil Sodium in Patients With Severe Pulmonary Arterial Hypertension

NCT00147199 is registered in ClinicalTrials.gov with United Therapeutics as lead sponsor.

NCT NCT00147199
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00147199 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
TRIUMPH I: Double Blind Placebo Controlled Clinical Investigation Into the Efficacy and Tolerability of Inhaled Treprostinil Sodium in Patients With Severe Pulmonary Arterial Hypertension
Lead sponsor
United Therapeutics
Phase
Phase 3
Overall status
Completed
Start date
June 30, 2005
Completion date
October 31, 2007
Enrollment
235 (actual)
Sites
30

Conditions

As the registry lists them; a condition with its own page is linked.

pulmonary hypertension